US.HUM · Humana

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.5150341031015158,
        "turnoverUsdM": 336.40115309739,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 369.7972,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 0.5,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7,
      "take_profit_price": 417.648,
      "target_multiplier": 1.6,
      "technical_strength": 1.13,
      "take_profit_percent": 5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.0300682062030315,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 58.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 0
  },
  "market": {
    "ma20": 379.996,
    "ma50": 328.3958,
    "close": 397.76,
    "prevClose": 396.29,
    "avgVolume20": 1469042,
    "volumeRatio": 0.58,
    "changePercent": 0.37
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 0,
    "details": {
      "ret_5d": -0.02847931150214167,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 0,
      "vcp_bonus": 0,
      "vol_ratio": 0.5643696761213303,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.903235149014154,
      "volat_points": 0,
      "day_range_pct": 0.03127514000213344,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 58.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 12.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 82.67,
        "contribution": 12.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 17.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 59.33,
        "contribution": 17.8
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.1,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 12.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 17.8/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 13.2,
      "市場環境": 12.4,
      "情緒分析": 4,
      "技術信號": 17.8,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 336.40115309739,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "優秀",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.9
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 720.9690033500002,
                "ma50": 713.79420164,
                "name": "QQQ",
                "close": 723.17999,
                "points": 2
              },
              "spy": {
                "ma20": 742.33551,
                "ma50": 740.3722033000001,
                "name": "SPY",
                "close": 751.71002,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.5150341031015158,
          "atrPoints": 2,
          "cciPoints": 4,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 7,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 1
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140727523,
                "url": "https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.",
                "category": "company",
                "datetime": 1782406670,
                "headline": "Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"
              },
              {
                "id": 140722892,
                "url": "https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...",
                "category": "company",
                "datetime": 1782367644,
                "headline": "Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"
              },
              {
                "id": 140721384,
                "url": "https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...",
                "category": "company",
                "datetime": 1782353311,
                "headline": "Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"
              },
              {
                "id": 140701640,
                "url": "https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]",
                "category": "company",
                "datetime": 1782220201,
                "headline": "Here’s What Hit Humana (HUM) in Q1"
              },
              {
                "id": 140635687,
                "url": "https://finnhub.io/api/news?id=a29f09bb8ec5f049f51b972a8b78636e85643c5aec71421d90f713968e0a54ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 8, JPMorgan analyst Lisa Gill raised the firm’s price target on Humana Inc. (NYSE:HUM) to $316 from $214 and maintained a Neutral rating on the shares. The firm updated its healthcare services models. The same day, Mizuho raised its price […]",
                "category": "company",
                "datetime": 1781500281,
                "headline": "JPMorgan and Mizuho Raise Humana (HUM) Price Targets as Managed Care Outlook Improves"
              },
              {
                "id": 140628537,
                "url": "https://finnhub.io/api/news?id=1b498ce6dc6c1aaf82bf6183bcc6745eb577c559b48b3bc48c565abad17a4ac9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) is one of the 7 Best Turnaround Stocks to Buy in 2026. On June 8, 2026, Mizuho raised the firm’s price target on Humana Inc. (NYSE:HUM) to $390 from $335 and maintained an Outperform rating on the shares. The firm said the managed care sector is entering a “more stable and predictable” […]",
                "category": "company",
                "datetime": 1781369584,
                "headline": "Mizuho Raises its Price Target on Humana (HUM)"
              }
            ],
            "raw_source": [
              {
                "id": 140854725,
                "url": "https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”",
                "category": "company",
                "datetime": 1783622061,
                "headline": "Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"
              },
              {
                "id": 140851085,
                "url": "https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.",
                "category": "company",
                "datetime": 1783604827,
                "headline": "The Real Price of UnitedHealth Stock Isn't on Today's Label"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140843416,
                "url": "https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.",
                "category": "company",
                "datetime": 1783524300,
                "headline": "UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"
              },
              {
                "id": 140834545,
                "url": "https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.",
                "category": "company",
                "datetime": 1783430767,
                "headline": "Humana Earnings Preview: What to Expect"
              },
              {
                "id": 140830888,
                "url": "https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.",
                "category": "company",
                "datetime": 1783410797,
                "headline": "Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"
              },
              {
                "id": 140822476,
                "url": "https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.",
                "category": "company",
                "datetime": 1783354301,
                "headline": "What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"
              },
              {
                "id": 140819581,
                "url": "https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.",
                "category": "company",
                "datetime": 1783327970,
                "headline": "CVS Health: The Surprising Healthcare Outlier"
              },
              {
                "id": 140807752,
                "url": "https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]",
                "category": "company",
                "datetime": 1783174832,
                "headline": "Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"
              },
              {
                "id": 140799596,
                "url": "https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.",
                "category": "company",
                "datetime": 1783081253,
                "headline": "The Unpopular Move That Telegraphed the Elevance Health Stock Surge"
              },
              {
                "id": 140791579,
                "url": "https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.",
                "category": "company",
                "datetime": 1782999120,
                "headline": "PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140772839,
                "url": "https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,",
                "category": "company",
                "datetime": 1782828758,
                "headline": "UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"
              },
              {
                "id": 140772135,
                "url": "https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.",
                "category": "company",
                "datetime": 1782820800,
                "headline": "The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"
              },
              {
                "id": 140771643,
                "url": "https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.",
                "category": "company",
                "datetime": 1782819000,
                "headline": "Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"
              },
              {
                "id": 140774740,
                "url": "https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.",
                "category": "company",
                "datetime": 1782808093,
                "headline": "Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"
              },
              {
                "id": 140781618,
                "url": "https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec",
                "image": "https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.",
                "category": "company",
                "datetime": 1782795601,
                "headline": "Medicare will start covering obesity drugs for the first time. Here's what patients should know"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140762586,
                "url": "https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.",
                "category": "company",
                "datetime": 1782744240,
                "headline": "How CenterWell Is Driving Humana's Growth Beyond Insurance"
              },
              {
                "id": 140761652,
                "url": "https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.",
                "category": "company",
                "datetime": 1782737415,
                "headline": "2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"
              },
              {
                "id": 140738020,
                "url": "https://finnhub.io/api/news?id=21eee8397f16e7d74095ad3cf7e8fc458841490e5fdbb2389cbf7c1ad40e1088",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.",
                "category": "company",
                "datetime": 1782488700,
                "headline": "Can Carelon Drive Elevance Health's Future Earnings Growth?"
              },
              {
                "id": 140739246,
                "url": "https://finnhub.io/api/news?id=47ec2a2209086a44ad157e6195ed8a0ffc0e3023569ffaf896991b26b1a9e44d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1782480916,
                "headline": "4 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140727523,
                "url": "https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.",
                "category": "company",
                "datetime": 1782406670,
                "headline": "Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"
              },
              {
                "id": 140722892,
                "url": "https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...",
                "category": "company",
                "datetime": 1782367644,
                "headline": "Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"
              },
              {
                "id": 140721384,
                "url": "https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...",
                "category": "company",
                "datetime": 1782353311,
                "headline": "Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"
              },
              {
                "id": 140715750,
                "url": "https://finnhub.io/api/news?id=392deaad22fa5d18fbbb3de9a0bc3c25155defe608767ed47db42f65e079bfee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.",
                "category": "company",
                "datetime": 1782314700,
                "headline": "Can Humana's Margin Recovery Drive Long-Term Earnings Growth?"
              },
              {
                "id": 140717417,
                "url": "https://finnhub.io/api/news?id=f93a7b0ca1dfb02867de7f467ea74e8f67e8135f808359459d41c664d4a49722",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "B of A Securities  analyst Kevin Fischbeck   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $340 to $380.",
                "category": "company",
                "datetime": 1782306501,
                "headline": "B of A Securities Maintains Neutral on Humana, Raises Price Target to $380"
              },
              {
                "id": 140701640,
                "url": "https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]",
                "category": "company",
                "datetime": 1782220201,
                "headline": "Here’s What Hit Humana (HUM) in Q1"
              },
              {
                "id": 140700233,
                "url": "https://finnhub.io/api/news?id=c38b12817fb689102db462d2ccc0c2143ee8414e2dbef5846012f7b7e08a8efc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]",
                "category": "company",
                "datetime": 1782203748,
                "headline": "CVS Health (CVS) Under the Microscope After Recent Healthcare Report"
              },
              {
                "id": 140696392,
                "url": "https://finnhub.io/api/news?id=89966c567aa0ab9e59469cab4e15beaf49cb48582424b9116a541e6eceb483af",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 22, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.",
                "category": "company",
                "datetime": 1782160200,
                "headline": "Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026"
              },
              {
                "id": 140695049,
                "url": "https://finnhub.io/api/news?id=2e2c3f7497742be1643d4d2e86e0e0da6e322ecfb2e9f5e7b47237a31fca7eea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.",
                "category": "company",
                "datetime": 1782147060,
                "headline": "UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?"
              },
              {
                "id": 140670778,
                "url": "https://finnhub.io/api/news?id=bd1ba6eea0be8b23e57da68e8f92f21d120cf2fa9b34ed6a99ffd07d72b5c036",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1781882218,
                "headline": "1 S&P 500 Stock on Our Buy List and 2 We Ignore"
              },
              {
                "id": 140670004,
                "url": "https://finnhub.io/api/news?id=33a5887422971ea693f377a69701553c8ff339624ea7d20c1726ffa301283a0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...",
                "category": "company",
                "datetime": 1781871116,
                "headline": "UnitedHealth (UNH) Joins Optura As Former Humana And CVS Chiefs Sign On"
              },
              {
                "id": 140663313,
                "url": "https://finnhub.io/api/news?id=dfefa937c73e1028e63f187f3dc3fd241e34d9a0f4ea7c8917b5c00c2affc29f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.",
                "category": "company",
                "datetime": 1781798248,
                "headline": "2 High-Flying Stocks to Target This Week and 1 Facing Challenges"
              },
              {
                "id": 140669985,
                "url": "https://finnhub.io/api/news?id=3befb971a581643ef5598128a12003139593bfcadd0c717c21c370431db4c2ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.",
                "category": "company",
                "datetime": 1781789400,
                "headline": "3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound"
              },
              {
                "id": 140662486,
                "url": "https://finnhub.io/api/news?id=e95c2dd2427c646b59ca687256cb6365d1581d8409a47d6c6504ec991f1c20cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Optura, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced that Bruce Broussard, former President and CEO of Humana, and Karen Lynch, former President and CEO of CVS Health, have joined the company as strategic advisors, alongside a broader group of advisors from Humana, Optum, UnitedHealth Group, Horizon Blue Cross Blue Shield, BlueCross BlueShield of Tennessee, and Boston Consulting Group.",
                "category": "company",
                "datetime": 1781787600,
                "headline": "Bruce Broussard and Karen Lynch Lead a Group of Healthcare and Music Industry Luminaries Joining Optura as Strategic Advisors"
              },
              {
                "id": 140652753,
                "url": "https://finnhub.io/api/news?id=f816292c4cc1a836354f9db6258b904847bb65dcad6c9dd3e2a121251f9b0be8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 17, 2026--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State",
                "category": "company",
                "datetime": 1781697600,
                "headline": "Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State"
              },
              {
                "id": 140645758,
                "url": "https://finnhub.io/api/news?id=920d7e0373fa1f369733ebdb85721d3ee12e827e4bb631d1c07561d28b3c699d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.",
                "category": "company",
                "datetime": 1781624687,
                "headline": "Why Did UnitedHealth Stock Choose Pain Over Growth?"
              },
              {
                "id": 140644635,
                "url": "https://finnhub.io/api/news?id=a0cb1ba10580396788827af3aae39c4050267d5c2d9d9d8e7b5e974e1ea28020",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 16, 2026--Humana, CenterWell and National Hispanic Medical Association announce 2026 Resident Physician Scholarship Program recipients.",
                "category": "company",
                "datetime": 1781607600,
                "headline": "Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients"
              },
              {
                "id": 140637274,
                "url": "https://finnhub.io/api/news?id=84ae8efd60969e59b2ea23c870b4c95c9a8744d281aca256d01f827f6b8ad3c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Eyebuydirect, a leading online destination for high-quality, affordable prescription eyewear, is celebrating 20 years of helping people see clearly and express their personal style. Since launching in 2006 with a catalog of just 100 frame styles, the brand has grown into a global eyewear destination that has sold more than 30 million pairs of glasses and served over 8 million customers across 40 countries.",
                "category": "company",
                "datetime": 1781528400,
                "headline": "EYEBUYDIRECT CELEBRATES 20 YEARS IN BUSINESS AND 30 MILLION PAIRS SOLD - AND COUNTING"
              },
              {
                "id": 140636516,
                "url": "https://finnhub.io/api/news?id=2cc935ab374eb134c3c326318b7dda59e0c9d1c8ffdc4e18ac759640c50c6247",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group Incorporated (NYSE:UNH) was among the stocks Jim Cramer highlighted during Mad Money, as he noted the rotation into defensive sectors. Cramer called the company’s CEO “legendary,” as he commented: Finally, we have UnitedHealth. It’s another managed care play that’s up for the same reason as Humana. The stock pulled back this afternoon, but […]",
                "category": "company",
                "datetime": 1781512122,
                "headline": "Jim Cramer on UnitedHealth: “Buy It”"
              },
              {
                "id": 140636538,
                "url": "https://finnhub.io/api/news?id=e1285f55d69564b7677053b78a96f4ff777f4c7fb320a9289c701b7ccfc3b76c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) was among the stocks Jim Cramer highlighted during Mad Money, as he noted the rotation into defensive sectors. Cramer highlighted an “unexpected gift” for the company, as he remarked: Then back to defense, Humana, the giant health insurer, got a… huge break from the Trump administration not that long ago when it […]",
                "category": "company",
                "datetime": 1781510704,
                "headline": "Jim Cramer on Humana: “This Is a Textbook Safety Stock”"
              },
              {
                "id": 140635687,
                "url": "https://finnhub.io/api/news?id=a29f09bb8ec5f049f51b972a8b78636e85643c5aec71421d90f713968e0a54ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 8, JPMorgan analyst Lisa Gill raised the firm’s price target on Humana Inc. (NYSE:HUM) to $316 from $214 and maintained a Neutral rating on the shares. The firm updated its healthcare services models. The same day, Mizuho raised its price […]",
                "category": "company",
                "datetime": 1781500281,
                "headline": "JPMorgan and Mizuho Raise Humana (HUM) Price Targets as Managed Care Outlook Improves"
              },
              {
                "id": 140628537,
                "url": "https://finnhub.io/api/news?id=1b498ce6dc6c1aaf82bf6183bcc6745eb577c559b48b3bc48c565abad17a4ac9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) is one of the 7 Best Turnaround Stocks to Buy in 2026. On June 8, 2026, Mizuho raised the firm’s price target on Humana Inc. (NYSE:HUM) to $390 from $335 and maintained an Outperform rating on the shares. The firm said the managed care sector is entering a “more stable and predictable” […]",
                "category": "company",
                "datetime": 1781369584,
                "headline": "Mizuho Raises its Price Target on Humana (HUM)"
              },
              {
                "id": 140615026,
                "url": "https://finnhub.io/api/news?id=3b641f318a1ee0d3c28df5cd04fa330a87c1c6e1edb7b354bc4ed3085e8e431a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) agreed to sell its minority stake in Gentiva for approximately US$900 million, exiting equity ownership in home health, palliative, and hospice care. The insurer was also selected as a winner in Illinois' Medicaid managed care program, adding a new state contract to its government focused portfolio. For a company centered on Medicare Advantage and other government backed insurance, these moves represent a meaningful repositioning of how Humana (NYSE:HUM) is exposed to care...",
                "category": "company",
                "datetime": 1781241172,
                "headline": "Humana Reshapes Care Exposure With Gentiva Exit And Illinois Medicaid Win"
              },
              {
                "id": 140610641,
                "url": "https://finnhub.io/api/news?id=3cb33f75c22501ac6db425b2c5cfae2448e8f55373dde92676ed9b018d9ce277",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.",
                "category": "company",
                "datetime": 1781198340,
                "headline": "Humana Closes the Kindred Chapter With $900 Million Gentiva Exit"
              },
              {
                "id": 140612793,
                "url": "https://finnhub.io/api/news?id=acc2050b1279313bfab624837c5a821156fe9c632b5e3a73cdc4917cb837e5c2",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Evercore ISI Group  analyst Elizabeth Suzuki   maintains Humana (NYSE:HUM) with a In-Line and raises the price target from $250 to $370.",
                "category": "company",
                "datetime": 1781172266,
                "headline": "Evercore ISI Group Maintains In-Line on Humana, Raises Price Target to $370"
              },
              {
                "id": 140607363,
                "url": "https://finnhub.io/api/news?id=89fb26a6f646d98f270337a7c4e50790f7adfe88369df1d60393db6bc9ab1ccf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The insurer is offloading its interest in the massive end-of-life care provider to an undisclosed group of investors, amid widespread concern about private investors’ activity in healthcare.",
                "category": "company",
                "datetime": 1781169882,
                "headline": "Humana divests interest in end-of-life provider Gentiva valued at $900M"
              },
              {
                "id": 140606573,
                "url": "https://finnhub.io/api/news?id=6e92616869006ab355fc58712acae297e3390c198f7e033b74c9d17c0cfe9713",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/11/Medicare-Advantage-Type-Of-Health-Insura.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Federal investigators found Medicare Advantage plans frequently denied requests for nursing and rehabilitation care, with many decisions later overturned on appeal.",
                "category": "company",
                "datetime": 1781166049,
                "headline": "Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns"
              },
              {
                "id": 140599369,
                "url": "https://finnhub.io/api/news?id=3513dd11be3fd02ea7e7961e0f02585ba3f844eb11a9a3dd827a0677addc756a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 10, 2026--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana’s minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for general c",
                "category": "company",
                "datetime": 1781123400,
                "headline": "Humana Announces Agreement to Divest Minority Interest in Gentiva"
              },
              {
                "id": 140703551,
                "url": "https://finnhub.io/api/news?id=4bc1071ffb1a396860e448aebcd4eea4e9ab3dc70bf4dbc29263d629071f777a",
                "image": "https://image.cnbcfm.com/api/v1/image/108319984-4ED3-MM-A-BLOCK-061026.jpg?v=1781130849&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "'Mad Money' host Jim Cramer looks at what is behind the market sell-off.",
                "category": "company",
                "datetime": 1781119989,
                "headline": "Jim Cramer on if 'boring' stocks are back in"
              },
              {
                "id": 140612795,
                "url": "https://finnhub.io/api/news?id=5010c14c6cc2868eb5a47f604bbbee715edc40558b6a4382f2e5e963957414b3",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation's leading provider ofHumana Inc.",
                "category": "company",
                "datetime": 1781109257,
                "headline": "Humana Agrees To Divest Minority Stake In Gentiva In Deal Valued At ~$900M; Other Financial Terms Not Disclosed"
              },
              {
                "id": 140592968,
                "url": "https://finnhub.io/api/news?id=b3014c0cbbdb96e60f4005b1f1f4cd3aa635606368eca13013a13d854d535285",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 10, 2026--Humana and CenterWell employees combined to donate more than $1.4 million to nonprofit organizations in just 24 hours during the Humana Foundation’s annual Double Match Day in April. During the event, more than 1,600 employees donated to a total of 1,650 nonprofits across the United States to support their communities.",
                "category": "company",
                "datetime": 1781096400,
                "headline": "Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours"
              },
              {
                "id": 140592783,
                "url": "https://finnhub.io/api/news?id=cd3422c8775300ffd0a4a15ccebefd6deea1613f7c3e9272550ea70859d11fda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy. Since Trump took office, healthcare and social services has added roughly 901,000 jobs, while every other part of the economy has actually lost jobs on net. One sector hiring. Everything else shedding. Before ... Trump’s Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here’s Where to Put Your Money",
                "category": "company",
                "datetime": 1781094862,
                "headline": "Trump’s Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here’s Where to Put Your Money"
              },
              {
                "id": 140590984,
                "url": "https://finnhub.io/api/news?id=269a4b607700aab8636168ff3222a0eeaf6fe5ec715553ca04d5676d6a5829d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As Centene has notably outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781053545,
                "headline": "Is Centene Stock Outperforming the Dow?"
              },
              {
                "id": 140589921,
                "url": "https://finnhub.io/api/news?id=151f8df4305f3cfd68c2a01af74537a47eba6313c77924e278cf35c2cba84419",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "CVS Health posted other positive signs of growth, such as improved retail pharmacy market share. Read why CVS stock is a Buy.",
                "category": "company",
                "datetime": 1781048858,
                "headline": "CVS Offers A Compelling Turnaround Opportunity Not Seen In Years"
              },
              {
                "id": 140588266,
                "url": "https://finnhub.io/api/news?id=e09748f3d8043bb312e4c9180ff121b5ec6b2e560127e01dbc7d92b12b24b486",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As tech stocks have pulled back lately, weighing on the major indexes, healthcare stocks are surging ahead.",
                "category": "company",
                "datetime": 1781041565,
                "headline": "As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play"
              },
              {
                "id": 140581515,
                "url": "https://finnhub.io/api/news?id=35e92bf3255e651b6c76cb397f6019e2f2f7ad86cd0603d3d453dabdc158f506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The state said it intends to divvy out new contracts, which represent tens of billions of dollars in revenue for each awardee, to six insurers. Winners are mostly incumbents, except for Humana.",
                "category": "company",
                "datetime": 1781001687,
                "headline": "Illinois awards new Medicaid contracts"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 7,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1,
            "source_article_count": 58,
            "discarded_article_count": 51
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.8,
        "grade": "較差",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日3日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 1409820,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1374920,
              "avg_vol_20": 1498555,
              "avg_vol_30": 1409820,
              "range_pct_10": 0.15572204455646507,
              "range_pct_20": 0.15572204455646507,
              "range_pct_30": 0.2883396950839779,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9752450667461094,
              "dist_to_20d_high": 0.0415421445783132,
              "down_shrink_days": 2,
              "breakout_level_20d": 415,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5400645391926061
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.5150341031015158,
              "turnoverUsdM": 336.40115309739,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 369.7972,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 0.5,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7,
            "take_profit_price": 417.648,
            "target_multiplier": 1.6,
            "technical_strength": 1.13,
            "take_profit_percent": 5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.0300682062030315,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 13.9814,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.52
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 87.65
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0246
    },
    "kdj": {
      "d": 71.32,
      "j": 57.91,
      "k": 66.85,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 44.71
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 43583339,
      "recentSlope": 628423.9,
      "previousSlope": 12540
    },
    "rsi": 73.92,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 380.4515,
      "position": "SAR喺價下",
      "distancePct": 4.35,
      "previousTrend": "上升"
    },
    "ma50": 328.3958,
    "macd": {
      "macd": 20.23265417395629,
      "trend": "中性偏多",
      "signal": 21.781616833885867,
      "histogram": -1.5489626599295754
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 377.5426,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 41
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.58,
      "score": 2,
      "avgVolume": 1469042,
      "currentVolume": 845739
    },
    "derived": {
      "ma20": 379.996,
      "ma50": 328.3958,
      "prevClose": 396.29,
      "avgVolume10": 1293194,
      "avgVolume20": 1469042,
      "changePercent": 0.37,
      "avgVolumeForScore": 1469042
    },
    "ma_cross": {
      "ma20": 379.996,
      "ma50": 328.3958,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 378.267,
      "prevMa50": 324.913,
      "spreadPct": 15.71,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 348.8967,
      "upper": 411.0953,
      "position": "上半部"
    },
    "rsi_short": 50.8,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.58
    }
  }
}

{
  "close": 397.76,
  "volume": 845739,
  "changePercent": 0.37
}